What is Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s (002940.SZ) StockRank?

MoatMap's StockRank for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) is 25/100, with a Sell signal. This is a composite score combining Quality (58), Value (25), and Momentum (33) factor ranks across MoatMap's 20,000+ stock universe.

Does Zhejiang AngLiKang Pharmaceutical CO.,LTD. have an economic moat?

Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) has a Quality factor score of 58/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Zhejiang AngLiKang Pharmaceutical CO.,LTD. a buy, hold, or sell?

MoatMap's current signal for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) is Sell, based on a StockRank of 25/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Zhejiang AngLiKang Pharmaceutical CO.,LTD. in?

Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002940.SZ

SELLREMOVE

Zhejiang AngLiKang Pharmaceutical CO.,LTD. · Healthcare · China · $1.0B · Avg Vol: $84M/d

StockRank

P/E (TTM)

44.5x

ROE

8.3%

D/E

0.3x

Dividend %

0.9%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

A manufacturer of active pharmaceutical ingredients (APIs) and preparations. It operates in a highly regulated, price-sensitive domestic market with low margins, failing the CDMO pricing power thesis.

COMPANY DESCRIPTION

Zhejiang AngLiKang Pharmaceutical Co., Ltd. manufactures active pharmaceutical ingredients (APIs) and finished dosage forms, specializing in cardiovascular and anti-infective drugs. The company is a leading domestic producer of cephalosporin APIs and alpha-keto acids, utilizing advanced enzymatic synthesis. It is a vertically integrated pharmaceutical manufacturer with strong regulatory compliance and export capabilities.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	232M	240M	227M	211M	-3.2%
EPS	0.09	0.10	0.06	0.09	-1.1%
Shares	202M	202M	202M	202M	0.0%
Debt	51M	87M	72M	66M	9.2%
Equity	222M	234M	226M	241M	2.7%
Op CF	27M	41M	37M	36M	9.7%
Inv CF	-77M	-25M	-68M	-13M	—
Fin CF	56M	2M	-46M	-24M	—

PRICE (1M)-15.7%

SMA 50SMA 200

$4.13

RSI (14)

19.5

52W High

$10.14

From 52W High

0.4%

SCORE BREAKDOWN

Quality

ROIC

9.0%70.6

ROE

8.3%66.8

GP/Assets

18.6%43.6

Op. Margin

8.9%63.7

FCF/Assets

3.0%61.8

Piotroski

—83.4

Int. Cover

14.9x70.3

D/E Ratio

0.30x43.0

Current Ratio

1.84x33.9

Value

P/E (TTM)

44.5x23.2

EV/EBITDA

23.6x15.4

P/FCF

549.4x17.0

P/B

3.3x35.8

P/S

4.0x47.6

Div Yield

0.9%24.7

Momentum

52W High %

41%13.2

RS 6M

-35%34.7

SMA 50/200

0.95x48.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

11%54.4

FUNDAMENTALS

Market Cap

$1.0B

P/E (Forward)

—

Gross Margin

38.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002940.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002940.SZ	Zhejiang AngLiKang Pharmaceutical CO.,LTD.(you)	$1.0B	25	SELL
300702.SZ	Zhejiang Tianyu Pharmaceutical Co., Ltd.	$989M	26	SELL
603567.SS	Heilongjiang ZBD Pharmaceutical Co., Ltd.	$994M	26	SELL
600422.SS	KPC Pharmaceuticals,Inc.	$999M	24	SELL
300363.SZ	Porton Pharma Solutions Ltd.	$1.2B	26	SELL
600252.SS	Guangxi Wuzhou Zhongheng Group Co., Ltd	$1.0B	29	SELL
688621.SS	Beijing Sun-Novo Pharmaceutical Research Co., Ltd.	$894M	26	SELL
600129.SS	Chongqing Taiji Industry(Group) Co.,Ltd	$1.2B	23	SELL
688221.SS	Frontier Biotechnologies Inc.	$1.1B	21	SELL
688276.SS	Changchun BCHT Biotechnology Co.	$975M	21	SELL

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.1%

Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) — Stock Score Summary

Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) has a MoatMap StockRank of 25/100 based on Quality (58/100), Value (25/100), and Momentum (33/100) factor scores. The current signal is SELL. A manufacturer of active pharmaceutical ingredients (APIs) and preparations. It operates in a highly regulated, price-sensitive domestic market with low margins, failing the CDMO pricing power thesis.

Key Financial Metrics

Price	$4.13
Market Cap	$1.0B
P/E (TTM)	44.46
Price/Book	3.34
Return on Equity	8.3%
Return on Invested Capital	9.0%
Debt/Equity	30.21
Gross Margin	38.5%
Operating Margin	8.9%
Revenue Growth	-1.6%
Dividend Yield	0.9%
Free Cash Flow	$2M

Zhejiang AngLiKang Pharmaceutical CO.,LTD. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang AngLiKang Pharmaceutical CO.,LTD.’s (002940.SZ) StockRank?: MoatMap’s StockRank for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) is 25/100, with a Sell signal. It is a composite of Quality (58), Value (25), and Momentum (33) factor ranks across MoatMap’s 20,000+ stock universe.
Does Zhejiang AngLiKang Pharmaceutical CO.,LTD. have an economic moat?: Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) has a Quality factor score of 58/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang AngLiKang Pharmaceutical CO.,LTD. a buy, hold, or sell?: MoatMap’s current signal for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) is Sell, based on a StockRank of 25/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang AngLiKang Pharmaceutical CO.,LTD. in?: Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).